Alzheimer’s Benefits May Continue After Donanemab Treatment Ends, Data Suggest
(MedPage Today) — New data suggested that donanemab (Kisunla) sustained long-term benefits after a limited dosing period in a subgroup of people with early symptomatic Alzheimer’s disease.
Early Alzheimer’s patients who completed their course…
Share this Post
More Posts
Medicare Debuts Digital Health Record System for Enrollees
(MedPage Today) — WASHINGTON — Medicare enrollees will soon be able to export their medical records to their doctor or hospital under a program launched Thursday by CMS.
“Right now, our health information still feels stuck in the past,” Amy…
Parkinson’s Risk Tied to Newer Drinking Water Sources
(MedPage Today) — Drinking water from newer groundwater sources was linked with a higher risk of developing Parkinson’s disease, a U.S. population-based case-control study showed.
Parkinson’s risk was 24% higher when drinking water was sourced…
Raffle Offers a Picasso for 100 Euros to Fund Alzheimer’s Research
(MedPage Today) — Are you feeling lucky? A raffle in France is offering the chance to win a portrait by
